No Data
Accuray's (ARAY) Precision TPS Gets Approved by China's NMPA
Accuray's Precision Treatment Planning System Gains Approval in China
Lake Street Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6
Lake Street analyst Brooks O'Neil maintains $Accuray(ARAY.US)$ with a buy rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate of 44.5% and a total a
Accuray Precision TPS' Registration Dossier Approved in China
Express News | Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
Accuray(ARAY.US) Officer Sells US$4,597.1 in Common Stock
$Accuray(ARAY.US)$ Officer Pervaiz Ali sold 2,701 shares of common stock on Jun 4, 2024 at an average price of $1.702 for a total value of $4,597.1.Source: Announcement What is statement of changes in